The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Smart Drug Delivery Systems Market Projected To Become By 2030 Based On Its 2026 Valuation?
The smart drug delivery systems market size has seen rapid expansion in recent years. It is anticipated to increase from $15.06 billion in 2025 to $18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.5%. The historical growth of this market can be attributed to several factors, including the limitations inherent in conventional drug delivery methods, the rising incidence of chronic diseases, advancements in biomaterials, an enhanced focus on improving patient adherence, and significant pharmaceutical innovation.
The market for smart drug delivery systems is anticipated to experience significant expansion over the coming years. By 2030, this market is projected to reach $33.15 billion, exhibiting a compound annual growth rate (CAGR) of 16.5%. Factors contributing to this growth during the forecast period include the increasing demand for personalized therapies, the broader application of biologics, the integration of digital health solutions, supportive regulatory frameworks for combination devices, and advancements in nanotechnology. Key trends anticipated for the forecast period encompass the incorporation of AI-powered dosing, an increase in implantable delivery systems, a greater need for targeted drug delivery, the embrace of wireless connectivity, and the proliferation of combination drug-device products.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp
What Primary Drivers Are Shaping The Development Of The Smart Drug Delivery Systems Market?
The increasing prevalence of chronic diseases is projected to stimulate expansion within the smart drug delivery systems market in the foreseeable future. These long-term health conditions evolve gradually and frequently originate from complex factors. The growing occurrence of chronic diseases stems from an aging global demographic, various environmental factors, and inequities in healthcare availability. Smart drug delivery systems present a promising strategy for effectively managing chronic diseases by enhancing the impact of medication and improving patient adherence. For illustration, a report in April 2025 from the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated that in 2023, approximately 194 million U.S. adults, or 76.4%, reported experiencing at least one chronic condition. This prevalence stood at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising incidence of chronic diseases is a key driver for the smart drug delivery systems market.
What Segment Groups Are Identified Within The Smart Drug Delivery Systems Market?
The smart drug delivery systems market covered in this report is segmented –
1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral Drug Delivery Systems
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users
Subsegments:
1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors
3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors
4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors
5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors
6) By Other Products: Smart Syringes, Smart Patches, Smart Implants
How Are Trends Transforming The Smart Drug Delivery Systems Market Landscape?
Leading companies in the Smart Drug Delivery Systems market are concentrating on developing innovative solutions, such as advanced on-body delivery platforms, to enhance the administration of injectable therapies, improve patient convenience, and ensure precise dosing. These advanced on-body delivery platforms are wearable systems that deliver medication automatically and accurately over time, thereby increasing convenience, safety, and adherence to treatment. For instance, in October 2024, Stevanato Group, an Italy-based pharmaceutical solutions provider, launched its large-volume Vertiva 10 mL on-body delivery system platform at CPHI Milan. The platform is designed to support high-volume injectable therapies with enhanced usability, safety, and treatment adherence, addressing the increasing demand for patient-centric drug delivery solutions.
Which Companies Hold Significant Positions In The Smart Drug Delivery Systems Market?
Major companies operating in the smart drug delivery systems market are Johnson & Johnson, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Novo Nordisk, Becton Dickinson and Company, Baxter International Inc, Phillips-Medisize Corporation, ResMed Inc, West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation, Ypsomed Holding AG, Nemera, Gerresheimer AG, Haselmeier AG, SHL Medical, Aptar Pharma
Read the full smart drug delivery systems market report here:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
How Does The Smart Drug Delivery Systems Market Perform Across Major Global Regions?
North America was the largest region in the smart drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Smart Drug Delivery Systems Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=14796&type=smp
Browse Through More Reports Similar to the Global Smart Drug Delivery Systems Market 2026, By The Business Research Company
Electronic Drug Delivery Systems Global Market Report
Advanced Drug Delivery Systems Global Market Report
Pharmaceutical Drug Delivery Global Market Report
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model